Skip to main content

Table 1 Summary of cases of neuroendocrine carcinomas arising in Barrett’s esophagus

From: A neuroendocrine carcinoma with a well-differentiated adenocarcinoma component arising in Barrett’s esophagus: a case report and literature review

No.

Author

Age (y)

Sex

Chief complaints

Reflux symptoms

Siewert classification

Tumor size (mm)

T

N

M

Stage

Tumor type

Chromogranin

Synaptophysin

Treatment

Postoperative survival

1

Slavin (1994)

63

F

Dysphagia and weight loss

(+)

Type 2

50

1

1

1

IV

Pure NEC

(+)

(−)

Esophagogastrectomy

Died at 3 months

2

Saw (1997)

43

F

Epigastric pain

(+)

Type 1

25

N.A.

N.A.

N.A.

N.A.

NEC with adenocarcinoma

(+)

(+)

Esophagectomy

Alive at 36 months

3

Saint Martin (1999)

54

F

Dysphagia

(+)

Type 2

N.A.

N.A.

N.A.

N.A.

N.A.

Pure NEC

(−)

(+)

Esophagogastrectomy

N.A.

4

Chen (2000)

64

M

Dysphagia

(−)

Type 1

40

N.A.

N.A.

N.A.

N.A.

Pure NEC

N.A.

N.A.

CRT

Alive at 14 months

5

Wilson (2000)

51

M

Epigastric discomfort and dysphagia

(+)

Type 2

40

1b

0

0

IA

NEC with adenocarcinoma

(−)

(+)

Esophagogastrectomy

N.A.

6

Gonzalez (2003)

75

M

Anorexia, weight loss, and dysphagia

(+)

Type 2

45

2

0

0

IB

NEC with adenocarcinoma

(−)

(+)

Esophagogastrectomy

N.A.

7

Bibeau (2008)

54

M

Epigastric discomfort

(+)

Type 2

20

2

0

0

IB

NEC with adenocarcinoma

(+)

(+)

CRT and esophagectomy

Alive at 72 months

8

Markogiannakis (2008)

62

M

Epigastric pain, epigastric fullness, dysphagia, anorexia, and weight loss

(+)

Type 2

25

2

1

0

IIB

Pure NEC

(+)

(−)

CRT and esophagogastrectomy

N.A.

9

Current report

71

M

No symptoms

(−)

Type 2

10

1b

0

0

IA

NEC with adenocarcinoma

(+)

(+)

Proximal gastrectomy

Alive at 36 months

  1. N.A. not available, NEC neuroendocrine carcinoma, CRT chemoradiotherapy